Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a European diagnostics company with state-of-the-art genetic testing technology and products. Multiplicom, headquartered in Niel ... more
Agilent Technologies Opens Global Manufacturing Facility for Life Sciences Instruments
Agilent Technologies Inc. announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company’s Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.
“The opening of the LC/MS manufacturing facility marks a milestone in Agilent’s continued investment in Singapore, which began in 1970,” said Bill Sullivan, Agilent president and CEO. “Singapore is the ideal location for this facility as it will provide us with greater access to the life sciences instrument market in Asia. The new facility also will bring us closer to our customers, as the pharmaceutical and biopharmaceutical industries have become an important part of Singapore’s overall economy and investment strategy.”
The Agilent LC/MS facility is located within the Agilent Life Sciences Group Order Fulfillment Center, located at its Yishun, Singapore, site. The center will be responsible for efficient management of the supply-chain network -- including planning, procurement, value-added engineering and logistics. The center ensures that the LC/MS facility is able to efficiently and effectively deliver configurable solutions to customers worldwide while maintaining Agilent’s hallmark of quality.
Agilent Technologies Inc. announced that Dr. Rohit Bhargava has received an Agilent Thought Leader Award in recognition of his pioneering work in the development of infrared spectroscopic imaging, and its application to life sciences research. Dr. Bhargava is a founder professor of bioengin ... more
Agilent Technologies Inc. and Transcriptic Inc. have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research. Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating wit ... more
- Illuminating the contacts
- Routine blood test predicts how long cancer patients will survive
- NovogeneAIT Singapore and the Genome Institute of Singapore forge Public-Private Partnership
- Quick test to detect inflammation in diabetic patients developed
- Water and light 'flow' inspire ultrasensitive optical microfiber coupler sensor